Original Research

Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study

Wang W, Li R, Li H, Wang M, Wang J, Wang X, Zhou Q

ImmunoTargets and Therapy 2024, 13:399-412

Published Date: 19 August 2024